Company / Working Capital
PULSE BIOSCIENCES, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$75.5M
FY2025
5-year range
$28.1M / $109.4M
FY2021-FY2025
Trend
-31.0%
vs FY2024
Sector context
#136 of 160
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s working capital of $75M is lower than 85% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from $15M in FY2020 to $109M in FY2024.
Based on SEC 10-K filings.
$75M in FY2025 with a 5-year CAGR of +38.6%.
Improved from $39M to $75M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +10.4%
- 5-Year CAGR
- +38.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 160This company $75.5M Sector average $757.1M
▼
-90.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +38.6%, indicating consistent growth.
- In FY2025, working capital decreased 31.0% year-over-year.
- Ranks #136 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.5M | -31.0% |
| FY2024 | $109.4M | +183.3% |
| FY2023 | $38.6M | -31.2% |
| FY2022 | $56.2M | +99.8% |
| FY2021 | $28.1M | +90.5% |
| FY2020 | $14.8M | -32.8% |
| FY2019 | $21.9M | -61.7% |
| FY2018 | $57.3M | +57.9% |
| FY2017 | $36.3M | +131.8% |
| FY2016 | $15.6M | +368.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026